Functional Dyspepsia Treatment Using Virtual Reality

Description

The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.

Conditions

Functional Dyspepsia

Study Overview

Study Details

Study overview

The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.

Effectiveness and Safety of Virtual Reality for the Treatment of Functional Dyspepsia

Functional Dyspepsia Treatment Using Virtual Reality

Condition
Functional Dyspepsia
Intervention / Treatment

-

Contacts and Locations

Jacksonville

Mayo Clinic in Florida, Jacksonville, Florida, United States, 32224

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Symptoms of dyspepsia thought to represent functional dyspepsia, meeting Rome IV criteria
  • * Had an upper endoscopy and assessment for Helicobacter pylori; if a patient is found to have H. pylori, treatment with confirmed eradication (by stool antigen test or urea breath test) will be required before the patient is eligible for study inclusion.
  • * Patients will be considered for the study if they have undergone a complete history and physical examination during a previously scheduled consultation/evaluation visit with a gastroenterologist in the Mayo Clinic Florida General GI or Motility clinic.
  • * Symptoms are thought to represent an organic disorder (e.g., peptic ulcer disease, hepatitis, pancreatitis, inflammatory bowel disease, type I diabetes, a known malignancy, radiation-induced injury, an active infection, vasculitis, celiac disease), or patients have known uncontrolled GERD, esophagitis, eosinophilic esophagitis, or untreated H. pylori.
  • * Patients with gastroparesis or cyclic vomiting syndrome.
  • * Patients with prior surgery to the esophagus, stomach or duodenum.
  • * Patients taking opioids.
  • * Patients with motion sickness, vertigo, or a seizure disorder
  • * IBS symptoms are not predominant.

Ages Eligible for Study

18 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

David Cangemi, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2025-06